JXL069 is an experimental drug originally developed at the University of California, Los Angeles (UCLA), that functions as a potent and highly selective mitochondrial pyruvate carrier (MPC) inhibitor, effectively disrupting the regulated import of pyruvate into mitochondria, altering cellular energy metabolism, and demonstrating promising preclinical efficacy as a metabolic modulator in androgenetic alopecia through mechanistic validation in animal model studies.
Molekulargewicht:
439.31
Reinheit:
99.99%
CAS Nummer:
[2260696-63-5]
Formel:
C20H11F6N3O2
Target-Kategorie:
Others
T211169
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
